Sotyktu

head to head against clash football helmets fight combat

Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown

Takeda has won the battle of the TYK2 inhibitors, toppling Bristol Myers Squibb’s Sotyktu to strengthen its hand ahead of an anticipated plaque psoriasis launch next year.

Nick Paul Taylor Jun 11, 2026 7:00am

Graphic image of an arrow nailing the bullseye of a target

Alumis beams as pivotal data on Sotyktu rival drive stock surge

Jan 6, 2026 9:05am

Takeda looks to 2026 FDA filing for Sotyktu rival zasocitinib

Dec 18, 2025 7:55am

J&J's IL-23 drug defeats Sotyktu in phase 3 psoriasis trial

Sep 17, 2025 9:45am

J&J, Protagonist's oral psoriasis prospect bests BMS' Sotyktu

Mar 10, 2025 7:30am

decision path change of plans arrows business decision

BMS backs out of Dupixent fight, axing asset despite phase 3 win

Feb 7, 2025 6:26am